Further validation by immunohistochemistry showed that 66% (135/203) of primary colon cancers had positive UBD protein staining, whereas only 6% (12/203) of normal colonic epithelium were immunoreactive for UBD. The gene discussed is UBD; the disease is colonic neoplasm.